These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 119679)

  • 21. Surface markers, antigens, and receptors on murine T and B cells: part 2.
    Ahmed A; Smith AH
    Crit Rev Immunol; 1983; 4(1):19-94. PubMed ID: 6131792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinant specific suppression of antigen-induced T cell proliferation in the guinea pig. II. Determinant specific suppression of in vitro T cell responsiveness parallels a selective suppression of anti-hapten but not anti-carrier antibody responses.
    Baskin BL; Blake JT; Rosenthal AS
    J Immunol; 1980 Jan; 124(1):189-93. PubMed ID: 6153095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
    Rao VS; Mitchell MS
    J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of complement solubilized complexes with mouse peritoneal macrophages and their clearance and tissue uptake.
    Takahashi N; Fujita T; Takata Y; Tamura N
    Clin Exp Immunol; 1985 Jul; 61(1):176-82. PubMed ID: 3899427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoregulation by covalent antigen-antibody complexes. II. Suppression of a T-cell independent anti-hapten response.
    Tite JP; Taylor RB
    Immunology; 1979 Oct; 38(2):325-31. PubMed ID: 315923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of Fc receptors of lymphocytes, macrophages and other mammalian cells in immune processes].
    Liampert IM
    Usp Sovrem Biol; 1982; 94(1):67-82. PubMed ID: 6753399
    [No Abstract]   [Full Text] [Related]  

  • 27. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil effector functions triggered by Fc-gamma and/or complement receptors are dependent on B-ring hydroxylation pattern and physicochemical properties of flavonols.
    Moreira MR; Kanashiro A; Kabeya LM; Polizello AC; Azzolini AE; Curti C; Oliveira CA; T-do Amaral A; Lucisano-Valim YM
    Life Sci; 2007 Jul; 81(4):317-26. PubMed ID: 17610907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG-Fc receptors and the clinical relevance of their polymorphisms.
    de Haas M
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):825-31. PubMed ID: 11732118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocytosis, membrane recycling and Fc receptor function.
    Mellman IS
    Ciba Found Symp; 1982; (92):35-58. PubMed ID: 6924894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costimulation and endogenous MHC ligands contribute to T cell recognition.
    Wülfing C; Sumen C; Sjaastad MD; Wu LC; Dustin ML; Davis MM
    Nat Immunol; 2002 Jan; 3(1):42-7. PubMed ID: 11731799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The affinity threshold for antigenic triggering differs for tolerance susceptible immature precursors vs mature primary B cells.
    Riley RL; Klinman NR
    J Immunol; 1986 May; 136(9):3147-54. PubMed ID: 2420884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane.
    Perussia B; Acuto O; Terhorst C; Faust J; Lazarus R; Fanning V; Trinchieri G
    J Immunol; 1983 May; 130(5):2142-8. PubMed ID: 6339622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fc receptor-mediated desensitization of superoxide (O2-) generation response of guinea-pig macrophages and polymorphonuclear leucocytes.
    Yagawa K; Kaku M; Ichinose Y; Aida Y; Tomoda A
    Immunology; 1985 Aug; 55(4):629-38. PubMed ID: 2991127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation of macrophage complement receptor function in vitro. V. Studies on the mechanisms of ligation of macrophage Fc receptors required to trigger macrophages to signal T lymphocytes to elaborate the lymphokine that activates macrophage C3 receptors for phagocytosis.
    Griffin FM; Mullinax PJ
    J Immunol; 1985 Jul; 135(1):344-9. PubMed ID: 3889154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of mast cell triggering processes.
    Stanworth DR
    Monogr Allergy; 1979; 14():271-80. PubMed ID: 91952
    [No Abstract]   [Full Text] [Related]  

  • 38. Models of B lymphocyte activation in the immune response: a critical review.
    Gandolfi A; Giovenco MA; Strom R
    Ann Sclavo; 1978; 20(4):401-44. PubMed ID: 88924
    [No Abstract]   [Full Text] [Related]  

  • 39. Supported planar membranes in studies of cell-cell recognition in the immune system.
    McConnell HM; Watts TH; Weis RM; Brian AA
    Biochim Biophys Acta; 1986 Jun; 864(1):95-106. PubMed ID: 2941079
    [No Abstract]   [Full Text] [Related]  

  • 40. [Circulating immune complexes--their properties, methods of determination and importance for the diagnosis and therapy of diseases].
    Maneva A; Manev V
    Vutr Boles; 1987; 26(2):1-7. PubMed ID: 3300033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.